サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1597054

アジア太平洋の家禽用ワクチン市場の将来予測 (2031年まで) - 地域別分析：種類別、技術別、剤形別、疾患別、投与経路別、エンドユーザー別

Asia Pacific Poultry Vaccines Market Forecast to 2031 - Regional Analysis - by Type, Technology, Dosage Form, Disease, Route Of Administration, and End User

出版日
ページ情報
英文 136 Pages
納期
即納可能 即納可能とは
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=147.05円
アジア太平洋の家禽用ワクチン市場の将来予測 (2031年まで) - 地域別分析：種類別、技術別、剤形別、疾患別、投与経路別、エンドユーザー別
出版日: 2024年10月17日
発行: The Insight Partners
ページ情報: 英文 136 Pages
納期: 即納可能 即納可能とは
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

アジア太平洋の家禽用ワクチン市場は、2023年に7億5,266万米ドルと評価され、2031年には15億1,433万米ドルに達すると予測され、2023年から2031年までのCAGRは9.1%を記録すると推定されます。

大量ワクチン接種に対する政府の支援と革新的なスキームが、アジア太平洋の家禽用ワクチン市場を後押ししています。

世界の疾病負担 (GBD) の増加に伴い、世界各国の政府は家禽用ワクチン接種に対する支援を行っています。この支援には、集団予防接種スキームの立ち上げや、予防接種センターまたは戸別予防接種サービスによるいくつかの予防接種プログラムが含まれます。

2022年12月、インド政府は「家畜衛生・疾病管理スキーム」のようなスキームの立ち上げを発表しました。このスキームは中央政府または州が主導し、60：40の分担パターンで資金を提供します。また、この制度は「調査・技術革新、広報・啓発、研修・関連活動」を対象としており、100%中央が資金を拠出しています。

したがって、このような政府支援による集団予防接種の推進や革新的な制度の設計は、今後数年間の家禽市場の成長に有利な機会を提供すると予想されます。

アジア太平洋の家禽用ワクチン市場の概要

アジア太平洋の家禽用ワクチン市場は、中国、日本、インド、オーストラリア、韓国、その他のアジア太平洋諸国に区分されます。アジア太平洋の市場は、家畜伝染病の増加、人獣共通感染症の増加、大手企業の存在、様々な政府機関や動物協会による取り組みなどの要因により、大きく成長することが期待されています。さらに、医療インフラの開発や一人当たりの動物医療支出の増加が、予測期間中のアジア太平洋家禽用ワクチン市場を牽引すると予測されます。

アジア太平洋の家禽用ワクチン市場の収益と、2031年までの予測 (単位：100万米ドル)

アジア太平洋の家禽用ワクチン市場セグメンテーション

アジア太平洋の家禽用ワクチン市場は、種類別、技術別、剤形別、疾患別、投与経路別、エンドユーザー別、国別に分類されます。

種類別では、アジア太平洋の家禽用ワクチン市場はブロイラーとレイヤーに二分されます。2023年にはブロイラー部門がより大きな市場シェアを占めています。

技術面では、アジア太平洋の家禽用ワクチン市場は弱毒生ワクチン、不活化ワクチン、組み換えワクチンに分類されます。2023年には弱毒生ワクチン分野が最大の市場シェアを占めました。

剤形別では、アジア太平洋の家禽用ワクチン市場は液体ワクチン、凍結乾燥ワクチン、粉末/粉体ワクチンに区分されます。2023年には液体ワクチンが最大の市場シェアを占めました。

疾患別では、アジア太平洋の家禽用ワクチン市場は鳥インフルエンザ、伝染性気管支炎、マレック病、鳥サルモネラ症、伝染性滑液包炎 (IBD)、ニューカッスル病、その他に分類されます。鳥インフルエンザ分野は2023年に最大の市場シェアを占めました。

投与経路別では、アジア太平洋の家禽用ワクチン市場は、飲料水 (D/W)、筋肉内投与 (I/M)、皮下投与 (I/S)、その他に区分されます。飲料水 (D/W) セグメントが2023年に最大の市場シェアを占めました。

エンドユーザー別では、アジア太平洋の家禽用ワクチン市場は養鶏場・孵化場、動物病院、家禽用ワクチン接種センター・クリニックに区分されます。養鶏場・孵化場のセグメントが2023年に最大の市場シェアを占めました。

国別では、アジア太平洋の家禽用ワクチン市場は中国、インド、日本、オーストラリア、韓国、その他のアジア太平洋諸国に区分されます。2023年には中国がアジア太平洋の家禽用ワクチン市場シェアを独占しました。

Boehringer Ingelheim International GmbH、Zoetis Inc、Phibro Animal Health Corp、Hester Biosciences Ltd、Venky's (India) Ltd、Dechra Pharmaceuticals PLC、Elanco Animal Health Inc、Merck KGaA、Ceva、Nisseiken Co Ltd、Vaccinova AB.は、アジア太平洋の家禽用ワクチン市場で事業を展開する主要企業です。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

  • 主要な洞察

第3章 調査手法

第4章 アジア太平洋の家禽用ワクチン市場：主な市場力学

  • 市場促進要因
    • 家禽疾病の有病率の上昇
    • 家禽産業の成長
  • 市場抑制要因
    • ワクチン接種の失敗と不適切な取り扱い
  • 市場機会
    • 大量ワクチン接種への政府の支援と革新的なスキーム
  • 今後の動向
    • ベクターワクチン・混合ワクチンの進歩
  • 促進要因と抑制要因の影響

第5章 アジア太平洋の家禽用ワクチン市場の分析

  • 家禽用ワクチンの市場収益 (2021～2031年)

第6章 アジア太平洋の家禽用ワクチン市場の分析：種類別

  • ブロイラー (肉用鶏)
  • レイヤー (卵用鶏)

第7章 アジア太平洋の家禽用ワクチン市場の分析：技術別

  • 生ワクチン
  • 不活化ワクチン
  • 組み換えワクチン

第8章 アジア太平洋の家禽用ワクチン市場の分析：剤形別

  • 液体ワクチン
  • フリーズドライワクチン
  • 粉末ワクチン

第9章 アジア太平洋の家禽用ワクチン市場の分析：疾患別

  • 鳥インフルエンザ
  • 鳥サルモネラ症
  • マレック病
  • 感染性気管支炎 (IB)
  • 感染性滑液包炎 (IBD)
  • ニューカッスル病
  • その他

第10章 アジア太平洋の家禽用ワクチン市場の分析：投与経路別

  • 飲料水 (D/W)
  • 筋肉内投与 (I/M)
  • 皮下投与 (S/C)
  • その他

第11章 アジア太平洋の家禽用ワクチン市場の分析：エンドユーザー別

  • 養鶏場
  • 動物病院
  • 家禽用ワクチン接種センター、診療所

第12章 アジア太平洋の家禽用ワクチン市場：国別分析

  • アジア太平洋市場の概要
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • その他のアジア太平洋諸国

第13章 業界情勢

  • 家禽用ワクチン市場における成長戦略
  • 有機的展開
  • 無機的展開

第14章 企業プロファイル

  • Boehringer Ingelheim International GmbH
  • Zoetis Inc
  • Phibro Animal Health Corp
  • Hester Biosciences Ltd
  • Venky's (India) Ltd
  • Dechra Pharmaceuticals PLC
  • Elanco Animal Health Inc
  • Merck KGaA
  • Ceva
  • Nisseiken Co Ltd
  • Vaccinova AB

第15章 付録

図表

List Of Tables

  • Table 1. Asia Pacific Poultry Vaccines Market Segmentation
  • Table 2. China: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Type
  • Table 3. China: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Technology
  • Table 4. China: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Dosage Form
  • Table 5. China: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Disease
  • Table 6. China: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Route of Administration
  • Table 7. China: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by End User
  • Table 8. India: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Type
  • Table 9. India: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Technology
  • Table 10. India: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Dosage Form
  • Table 11. India: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Disease
  • Table 12. India: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Route of Administration
  • Table 13. India: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by End User
  • Table 14. Japan: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Type
  • Table 15. Japan: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Technology
  • Table 16. Japan: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Dosage Form
  • Table 17. Japan: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Disease
  • Table 18. Japan: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Route of Administration
  • Table 19. Japan: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by End User
  • Table 20. Australia: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Type
  • Table 21. Australia: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Technology
  • Table 22. Australia: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Dosage Form
  • Table 23. Australia: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Disease
  • Table 24. Australia: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Route of Administration
  • Table 25. Australia: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by End User
  • Table 26. South Korea: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Type
  • Table 27. South Korea: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Technology
  • Table 28. South Korea: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Dosage Form
  • Table 29. South Korea: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Disease
  • Table 30. South Korea: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Route of Administration
  • Table 31. South Korea: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by End User
  • Table 32. Rest of APAC: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Type
  • Table 33. Rest of APAC: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Technology
  • Table 34. Rest of APAC: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Dosage Form
  • Table 35. Rest of APAC: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Disease
  • Table 36. Rest of APAC: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by Route of Administration
  • Table 37. Rest of APAC: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million) - by End User
  • Table 38. Organic Developments Done by Companies
  • Table 39. Inorganic Developments Done by Companies
  • Table 40. Glossary of Terms, Poultry Vaccines Market

List Of Figures

  • Figure 1. Asia Pacific Poultry Vaccines Market Segmentation, by Country
  • Figure 2. Poultry Vaccines Market - Key Market Dynamics
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. Poultry Vaccines Market Revenue (US$ Million), 2021-2031
  • Figure 5. Poultry Vaccines Market Share (%) - by Type, 2023 and 2031
  • Figure 6. Broiler: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 7. Layer: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 8. Poultry Vaccines Market Share (%) - by Technology, 2023 and 2031
  • Figure 9. Live Attenuated Vaccines: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 10. Inactivated Vaccines: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 11. Recombinant Vaccines: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 12. Poultry Vaccines Market Share (%) - by Dosage Form, 2023 and 2031
  • Figure 13. Liquid Vaccines: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 14. Freeze-Dried Vaccines: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 15. Dust/Powdered Vaccines: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 16. Poultry Vaccines Market Share (%) - by Disease, 2023 and 2031
  • Figure 17. Avian Influenza: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 18. Avian Salmonellosis: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 19. Marek's Disease: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 20. Infectious Bronchitis (IB): Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 21. Infectious Bursal Disease (IBD): Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 22. Newcastle Disease: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 23. Others: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 24. Poultry Vaccines Market Share (%) - by Route of Administration, 2023 and 2031
  • Figure 25. Drinking Water (D/W): Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 26. Intramuscular (I/M): Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 27. Subcutaneous (S/C): Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 28. Others: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 29. Poultry Vaccines Market Share (%) - by End User, 2023 and 2031
  • Figure 30. Poultry Farms: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 31. Veterinary Hospitals: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 32. Poultry Vaccination Centers & Clinics: Poultry Vaccines Market- Revenue and Forecast to 2031 (US$ Million)
  • Figure 33. Asia Pacific: Poultry Vaccines Market - Revenue by Key Countries 2023 (US$ Million)
  • Figure 34. Poultry Vaccines Market Breakdown by Key Countries, 2023 and 2031 (%)
  • Figure 35. China: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 36. India: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 37. Japan: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 38. Australia: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 39. South Korea: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 40. Rest of APAC: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 41. Growth Strategies in the Poultry Vaccines Market
目次
Product Code: TIPRE00023750

The Asia Pacific poultry vaccines market was valued at US$ 752.66 million in 2023 and is expected to reach US$ 1,514.33 million by 2031; it is estimated to record a CAGR of 9.1% from 2023 to 2031.

Government Support for Mass Vaccination Drives and Innovative Schemes Boost Asia Pacific Poultry Vaccines Market

Government worldwide is supportive against poultry vaccination with rising Global Burden of Disease (GBD). The support involves launching of mass vaccination schemes and several vaccination programs at vaccination centers or through door-step immunization services.

In December 2022, the Indian Government announced launching of schemes such as the "Livestock Health & Disease Control Scheme" improve the animal health sector by implementing prophylactic vaccination programs against several diseases. This scheme is Central or State-driven and funded with a sharing pattern of 60:40. Also, the scheme covers "research & innovation, publicity & awareness, training & allied activities" that are 100% Center-funded.

Therefore, such government support for mass vaccination drives and designing innovative schemes is anticipated to provide lucrative opportunities for the poultry market growth in the coming years.

Asia Pacific Poultry Vaccines Market Overview

The Asia Pacific poultry vaccines market is segmented into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. The market in Asia Pacific is expected to grow considerably owing to factors such as the increasing incidences of livestock diseases, the rising incidences of zoonotic diseases, the presence of leading players, and initiatives taken by various government agencies and animal associations. Further, developing healthcare infrastructure and increasing per capita animal healthcare expenditure are projected to drive the Asia Pacific poultry vaccines market during the forecast period.

Asia Pacific Poultry Vaccines Market Revenue and Forecast to 2031 (US$ Million)

Asia Pacific Poultry Vaccines Market Segmentation

The Asia Pacific poultry vaccines market is categorized into type, technology, dosage form, disease, route of administration, end user, and country.

Based on type, the Asia Pacific poultry vaccines market is bifurcated into broiler and layer. The broiler segment held a larger market share in 2023.

In terms of technology, the Asia Pacific poultry vaccines market is categorized into live attenuated vaccines, inactivated vaccines, and recombinant vaccines. The live attenuated vaccines segment held the largest market share in 2023.

By dosage form, the Asia Pacific poultry vaccines market is segmented into liquid vaccines, freeze-dried vaccines, and dust/powdered form vaccines. The liquid vaccines segment held the largest market share in 2023.

Based on disease, the Asia Pacific poultry vaccines market is categorized into avian influenza, infectious bronchitis, Marek's disease, avian salmonellosis, infectious bursal disease (IBD), Newcastle disease, and others. The avian influenza segment held the largest market share in 2023.

In terms of route of administration, the Asia Pacific poultry vaccines market is segmented into drinking water (D/W), intramuscular (I/M), subcutaneous (I/S), and others. The drinking water (D/W) segment held the largest market share in 2023.

Based on end user, the Asia Pacific poultry vaccines market is segmented into poultry farms & hatchery, veterinary hospitals, and poultry vaccination enters & clinics. The poultry farms & hatchery segment held the largest market share in 2023.

By country, the Asia Pacific poultry vaccines market is segmented into China, India, Japan, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific poultry vaccines market share in 2023.

Boehringer Ingelheim International GmbH, Zoetis Inc, Phibro Animal Health Corp, Hester Biosciences Ltd, Venky's (India) Ltd, Dechra Pharmaceuticals PLC, Elanco Animal Health Inc, Merck KGaA, Ceva, Nisseiken Co Ltd, and Vaccinova AB. are some of the leading companies operating in the Asia Pacific poultry vaccines market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

4. Asia Pacific Poultry Vaccines Market - Key Market Dynamics

  • 4.1 Market Drivers
    • 4.1.1 Rising Prevalence of Poultry Diseases
    • 4.1.2 Growing Poultry Industry
  • 4.2 Market Restraints
    • 4.2.1 Vaccination Failure and Improper Handling
  • 4.3 Market Opportunities
    • 4.3.1 Government Support for Mass Vaccination Drives and Innovative Schemes
  • 4.4 Future Trends
    • 4.4.1 Advancements in Vectored and Combination Vaccines
  • 4.5 Impact of Drivers and Restraints:

5. Asia Pacific Poultry Vaccines Market Analysis

  • 5.1 Poultry Vaccines Market Revenue (US$ Million), 2021-2031

6. Asia Pacific Poultry Vaccines Market Analysis - by Type

  • 6.1 Overview
  • 6.2 Broiler
    • 6.2.1 Overview
    • 6.2.2 Broiler: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • 6.3 Layer
    • 6.3.1 Overview
    • 6.3.2 Layer: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)

7. Asia Pacific Poultry Vaccines Market Analysis - by Technology

  • 7.1 Overview
  • 7.2 Live Attenuated Vaccines
    • 7.2.1 Overview
    • 7.2.2 Live Attenuated Vaccines: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.3 Inactivated Vaccines
    • 7.3.1 Overview
    • 7.3.2 Inactivated Vaccines: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.4 Recombinant Vaccines
    • 7.4.1 Overview
    • 7.4.2 Recombinant Vaccines: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)

8. Asia Pacific Poultry Vaccines Market Analysis - by Dosage Form

  • 8.1 Overview
  • 8.2 Liquid Vaccines
    • 8.2.1 Overview
    • 8.2.2 Liquid Vaccines: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.3 Freeze-Dried Vaccines
    • 8.3.1 Overview
    • 8.3.2 Freeze-Dried Vaccines: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.4 Dust/Powdered Vaccines
    • 8.4.1 Overview
    • 8.4.2 Dust/Powdered Vaccines: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)

9. Asia Pacific Poultry Vaccines Market Analysis - by Disease

  • 9.1 Overview
  • 9.2 Avian Influenza
    • 9.2.1 Overview
    • 9.2.2 Avian Influenza: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.3 Avian Salmonellosis
    • 9.3.1 Overview
    • 9.3.2 Avian Salmonellosis: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.4 Marek's Disease
    • 9.4.1 Overview
    • 9.4.2 Marek's Disease: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.5 Infectious Bronchitis (IB)
    • 9.5.1 Overview
    • 9.5.2 Infectious Bronchitis (IB): Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.6 Infectious Bursal Disease (IBD)
    • 9.6.1 Overview
    • 9.6.2 Infectious Bursal Disease (IBD): Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.7 Newcastle Disease
    • 9.7.1 Overview
    • 9.7.2 Newcastle Disease: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.8 Others
    • 9.8.1 Overview
    • 9.8.2 Others: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)

10. Asia Pacific Poultry Vaccines Market Analysis - by Route of Administration

  • 10.1 Overview
  • 10.2 Drinking Water (D/W)
    • 10.2.1 Overview
    • 10.2.2 Drinking Water (D/W): Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • 10.3 Intramuscular (I/M)
    • 10.3.1 Overview
    • 10.3.2 Intramuscular (I/M): Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • 10.4 Subcutaneous (S/C)
    • 10.4.1 Overview
    • 10.4.2 Subcutaneous (S/C): Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • 10.5 Others
    • 10.5.1 Overview
    • 10.5.2 Others: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)

11. Asia Pacific Poultry Vaccines Market Analysis - by End User

  • 11.1 Overview
  • 11.2 Poultry Farms
    • 11.2.1 Overview
    • 11.2.2 Poultry Farms: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • 11.3 Veterinary Hospitals
    • 11.3.1 Overview
    • 11.3.2 Veterinary Hospitals: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
  • 11.4 Poultry Vaccination Centers & Clinics
    • 11.4.1 Overview
    • 11.4.2 Poultry Vaccination Centers & Clinics: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)

12. Asia Pacific Poultry Vaccines Market - Country Analysis

  • 12.1 Asia Pacific Market Overview
    • 12.1.1 Poultry Vaccines Market Breakdown by Countries
      • 12.1.1.1 China: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
        • 12.1.1.1.1 Overview
        • 12.1.1.1.2 China: Poultry Vaccines Market Breakdown by Type
        • 12.1.1.1.3 China: Poultry Vaccines Market Breakdown by Technology
        • 12.1.1.1.4 China: Poultry Vaccines Market Breakdown by Dosage Form
        • 12.1.1.1.5 China: Poultry Vaccines Market Breakdown by Disease
        • 12.1.1.1.6 China: Poultry Vaccines Market Breakdown by Route of Administration
        • 12.1.1.1.7 China: Poultry Vaccines Market Breakdown by End User
      • 12.1.1.2 India: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
        • 12.1.1.2.1 Overview
        • 12.1.1.2.2 India: Poultry Vaccines Market Breakdown by Type
        • 12.1.1.2.3 India: Poultry Vaccines Market Breakdown by Technology
        • 12.1.1.2.4 India: Poultry Vaccines Market Breakdown by Dosage Form
        • 12.1.1.2.5 India: Poultry Vaccines Market Breakdown by Disease
        • 12.1.1.2.6 India: Poultry Vaccines Market Breakdown by Route of Administration
        • 12.1.1.2.7 India: Poultry Vaccines Market Breakdown by End User
      • 12.1.1.3 Japan: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
        • 12.1.1.3.1 Overview
        • 12.1.1.3.2 Japan: Poultry Vaccines Market Breakdown by Type
        • 12.1.1.3.3 Japan: Poultry Vaccines Market Breakdown by Technology
        • 12.1.1.3.4 Japan: Poultry Vaccines Market Breakdown by Dosage Form
        • 12.1.1.3.5 Japan: Poultry Vaccines Market Breakdown by Disease
        • 12.1.1.3.6 Japan: Poultry Vaccines Market Breakdown by Route of Administration
        • 12.1.1.3.7 Japan: Poultry Vaccines Market Breakdown by End User
      • 12.1.1.4 Australia: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
        • 12.1.1.4.1 Overview
        • 12.1.1.4.2 Australia: Poultry Vaccines Market Breakdown by Type
        • 12.1.1.4.3 Australia: Poultry Vaccines Market Breakdown by Technology
        • 12.1.1.4.4 Australia: Poultry Vaccines Market Breakdown by Dosage Form
        • 12.1.1.4.5 Australia: Poultry Vaccines Market Breakdown by Disease
        • 12.1.1.4.6 Australia: Poultry Vaccines Market Breakdown by Route of Administration
        • 12.1.1.4.7 Australia: Poultry Vaccines Market Breakdown by End User
      • 12.1.1.5 South Korea: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
        • 12.1.1.5.1 Overview
        • 12.1.1.5.2 South Korea: Poultry Vaccines Market Breakdown by Type
        • 12.1.1.5.3 South Korea: Poultry Vaccines Market Breakdown by Technology
        • 12.1.1.5.4 South Korea: Poultry Vaccines Market Breakdown by Dosage Form
        • 12.1.1.5.5 South Korea: Poultry Vaccines Market Breakdown by Disease
        • 12.1.1.5.6 South Korea: Poultry Vaccines Market Breakdown by Route of Administration
        • 12.1.1.5.7 South Korea: Poultry Vaccines Market Breakdown by End User
      • 12.1.1.6 Rest of APAC: Poultry Vaccines Market - Revenue and Forecast to 2031 (US$ Million)
        • 12.1.1.6.1 Overview
        • 12.1.1.6.2 Rest of APAC: Poultry Vaccines Market Breakdown by Type
        • 12.1.1.6.3 Rest of APAC: Poultry Vaccines Market Breakdown by Technology
        • 12.1.1.6.4 Rest of APAC: Poultry Vaccines Market Breakdown by Dosage Form
        • 12.1.1.6.5 Rest of APAC: Poultry Vaccines Market Breakdown by Disease
        • 12.1.1.6.6 Rest of APAC: Poultry Vaccines Market Breakdown by Route of Administration
        • 12.1.1.6.7 Rest of APAC: Poultry Vaccines Market Breakdown by End User

13. Industry Landscape

  • 13.1 Overview
  • 13.2 Growth Strategies in the Poultry Vaccines Market
  • 13.3 Organic Developments
    • 13.3.1 Overview
  • 13.1 Inorganic Developments
    • 13.1.1 Overview

14. Company Profiles

  • 14.1 Boehringer Ingelheim International GmbH
    • 14.1.1 Key Facts
    • 14.1.2 Business Description
    • 14.1.3 Products and Services
    • 14.1.4 Financial Overview
    • 14.1.5 SWOT Analysis
    • 14.1.6 Key Developments
  • 14.2 Zoetis Inc
    • 14.2.1 Key Facts
    • 14.2.2 Business Description
    • 14.2.3 Products and Services
    • 14.2.4 Financial Overview
    • 14.2.5 SWOT Analysis
    • 14.2.6 Key Developments
  • 14.3 Phibro Animal Health Corp
    • 14.3.1 Key Facts
    • 14.3.2 Business Description
    • 14.3.3 Products and Services
    • 14.3.4 Financial Overview
    • 14.3.5 SWOT Analysis
    • 14.3.6 Key Developments
  • 14.4 Hester Biosciences Ltd
    • 14.4.1 Key Facts
    • 14.4.2 Business Description
    • 14.4.3 Products and Services
    • 14.4.4 Financial Overview
    • 14.4.5 SWOT Analysis
    • 14.4.6 Key Developments
  • 14.5 Venky's (India) Ltd
    • 14.5.1 Key Facts
    • 14.5.2 Business Description
    • 14.5.3 Products and Services
    • 14.5.4 Financial Overview
    • 14.5.5 SWOT Analysis
    • 14.5.6 Key Developments
  • 14.6 Dechra Pharmaceuticals PLC
    • 14.6.1 Key Facts
    • 14.6.2 Business Description
    • 14.6.3 Products and Services
    • 14.6.4 Financial Overview
    • 14.6.5 SWOT Analysis
    • 14.6.6 Key Developments
  • 14.7 Elanco Animal Health Inc
    • 14.7.1 Key Facts
    • 14.7.2 Business Description
    • 14.7.3 Products and Services
    • 14.7.4 Financial Overview
    • 14.7.5 SWOT Analysis
    • 14.7.6 Key Developments
  • 14.8 Merck KGaA
    • 14.8.1 Key Facts
    • 14.8.2 Business Description
    • 14.8.3 Products and Services
    • 14.8.4 Financial Overview
    • 14.8.5 SWOT Analysis
    • 14.8.6 Key Developments
  • 14.9 Ceva
    • 14.9.1 Key Facts
    • 14.9.2 Business Description
    • 14.9.3 Products and Services
    • 14.9.4 Financial Overview
    • 14.9.5 SWOT Analysis
    • 14.9.6 Key Developments
  • 14.10 Nisseiken Co Ltd
    • 14.10.1 Key Facts
    • 14.10.2 Business Description
    • 14.10.3 Products and Services
    • 14.10.4 Financial Overview
    • 14.10.5 SWOT Analysis
    • 14.10.6 Key Developments
  • 14.11 Vaccinova AB
    • 14.11.1 Key Facts
    • 14.11.2 Business Description
    • 14.11.3 Products and Services
    • 14.11.4 Financial Overview
    • 14.11.5 SWOT Analysis
    • 14.11.6 Key Developments

15. Appendix

  • 15.1 About The Insight Partners
  • 15.2 Glossary of Terms